Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
AU638086B2 - Killing of activated lymphocytes - Google Patents
[go: Go Back, main page]

AU638086B2 - Killing of activated lymphocytes - Google Patents

Killing of activated lymphocytes

Info

Publication number
AU638086B2
AU638086B2 AU69543/91A AU6954391A AU638086B2 AU 638086 B2 AU638086 B2 AU 638086B2 AU 69543/91 A AU69543/91 A AU 69543/91A AU 6954391 A AU6954391 A AU 6954391A AU 638086 B2 AU638086 B2 AU 638086B2
Authority
AU
Australia
Prior art keywords
killing
activated lymphocytes
activated
lymphocytes
octadecylglycero
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU69543/91A
Other versions
AU6954391A (en
Inventor
Rabbe Nordstrom
Anneliese Schimpl
Eberhard Wecker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MedMark Pharma GmbH
Original Assignee
MedMark Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MedMark Pharma GmbH filed Critical MedMark Pharma GmbH
Publication of AU6954391A publication Critical patent/AU6954391A/en
Application granted granted Critical
Publication of AU638086B2 publication Critical patent/AU638086B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Luminescent Compositions (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

2-Methyl-1-octadecylglycero-(3)-phosphocholine is suitable for killing mammalian lymphocytes activated by antigens or mitogens.
AU69543/91A 1989-12-12 1990-12-11 Killing of activated lymphocytes Ceased AU638086B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3941009A DE3941009A1 (en) 1989-12-12 1989-12-12 ELIMINATION OF ACTIVATED LYMPHOCYTES
DE3941009 1989-12-12

Publications (2)

Publication Number Publication Date
AU6954391A AU6954391A (en) 1991-07-18
AU638086B2 true AU638086B2 (en) 1993-06-17

Family

ID=6395316

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69543/91A Ceased AU638086B2 (en) 1989-12-12 1990-12-11 Killing of activated lymphocytes

Country Status (13)

Country Link
EP (1) EP0505414B1 (en)
JP (1) JPH05504132A (en)
AT (1) ATE102038T1 (en)
AU (1) AU638086B2 (en)
CA (1) CA2071520C (en)
DE (2) DE3941009A1 (en)
DK (1) DK0505414T3 (en)
ES (1) ES2062754T3 (en)
FI (1) FI922710A0 (en)
HU (1) HU217586B (en)
NO (1) NO922304L (en)
RU (1) RU2100025C1 (en)
WO (1) WO1991008746A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5517234A (en) * 1993-10-26 1996-05-14 Gerber Systems Corporation Automatic optical inspection system having a weighted transition database
DE19822509A1 (en) * 1998-05-19 1999-11-25 Medmark Pharma Gmbh Edelfosin for the treatment of brain tumors
DE19829448A1 (en) * 1998-07-01 2000-10-12 Medmark Pharma Gmbh 1-Octadecyl-2-methyl-sn-glycero-3-phosphocholine (ET180CH3) for the treatment of human breast cancer
JP2009520730A (en) 2005-12-23 2009-05-28 ヤド・テヒノロギース・ゲーエムベーハー Means and methods for treating and preventing allergic diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3918082A1 (en) * 1989-06-02 1991-01-24 Max Planck Gesellschaft AGENT FOR AUTOIMMUNE DISEASES

Also Published As

Publication number Publication date
DE59004836D1 (en) 1994-04-07
ATE102038T1 (en) 1994-03-15
HU9201976D0 (en) 1992-09-28
DE3941009A1 (en) 1991-06-13
NO922304D0 (en) 1992-06-11
HUT60927A (en) 1992-11-30
HU217586B (en) 2000-02-28
NO922304L (en) 1992-06-11
CA2071520A1 (en) 1991-06-13
AU6954391A (en) 1991-07-18
JPH05504132A (en) 1993-07-01
ES2062754T3 (en) 1994-12-16
RU2100025C1 (en) 1997-12-27
EP0505414A1 (en) 1992-09-30
CA2071520C (en) 2002-10-01
FI922710A7 (en) 1992-06-11
WO1991008746A1 (en) 1991-06-27
DK0505414T3 (en) 1994-05-09
FI922710A0 (en) 1992-06-11
EP0505414B1 (en) 1994-03-02

Similar Documents

Publication Publication Date Title
AU6844790A (en) Novel a-nor-steriod-3-carboxylic acid derivatives
AU7873187A (en) Method of culturing leukocytes
AU568513B2 (en) Beta-carbolines
AU2945189A (en) Synthesis of 1,2-dioxetanes and intermediates therefor
AU8172094A (en) Synthetic HTLV-III peptides, compositions and uses thereof
EP0369262A3 (en) Novel pyrroles
ES8704911A1 (en) Process for the preparation of 1,3,5-triazine triones.
AU6036690A (en) Human monoclonal antibodies to hiv-1mn gp 120
AU638086B2 (en) Killing of activated lymphocytes
AP8800109A0 (en) "Heterocyclic insecticides".
AU5160690A (en) Detection of pyrogens by recombinant mammalian cells
EP0441948A4 (en) Synthesis of stable, water-soluble chemiluminescent 1,2-dioxetanes and intermediates therefor
EP0199085A3 (en) Jomol, its derivatives, process for the preparation of these substances, their use and their production
MY104318A (en) Novel thiopen compounds and their preparation
AU551250B2 (en) Preparation of satietin
TW340108B (en) 1,1-difluoro-1,4-dichlorobutane and process for its preparation
AU564040B2 (en) 1,2,3,4 - tetrahydro-1-aminomethyl-4-phenyl - isoquinolines
TW327175B (en) Process for preparing steroidal 3,5-diene-3-carboxylic acid derivatives
AU8724382A (en) Unsaturated halogenated diamines
EP0418990A3 (en) 13-bromo and 13,14-dibromo ergoline, their preparation and their use
EP0377127A3 (en) Use of Myricetin-3-O-beta-D glucuronide as medicament
EP0371762A3 (en) New platelet activating factor antagonists, named "the phomactins", their preparation and use
ES8703855A1 (en) Sulfonyl-guanidinotriazine derivatives.
White Fresnoite ceramics and thin films.
SU1178257A1 (en) Method and device for energy-mass-spectrum analysis of matter composition

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired